-
Famotidine for the Prevention of Peptic Ulcers in Users of Low-Dose Aspirin (FAMOUS)
Is this H2-blocker the solution to aspirin's GI drawbacks?
December 02, 2009
-
Excess Unfractionated Heparin Dosing for STEMI and NSTEMI
Standing orders developed for one use of heparin may not be appropriate for all uses of heparin.
December 02, 2009
-
Should Aspiration Thrombectomy Be Performed in All, Most, or Few Primary PCI Procedures?
The management of thrombus burden in STEMI patients treated with primary PCI remains a challenge. This review sifts the complex evidence and proposes a simple strategy.
December 02, 2009
-
Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
The TREAT trial tested the hypothesis that the use of erythropoiesis-stimulating agents would improve outcomes in patients with diabetes and chronic kidney disease who were also anemic.
November 25, 2009
-
Randomized On/Off Bypass trial (ROOBY)
Does the outcome of coronary artery bypass grafting differ, depending on whether the patient is on-pump or off-pump intraoperatively?
November 23, 2009
-
Overcoming the Barriers to Stem Cell Therapy
New approaches may enhance the survival, persistence, and proliferation of both injected and resident stem cells in the affected myocardium after myocardial infarction.
November 19, 2009
-
Study of Atherosclerosis with Ramipril and Rosiglitazone (STARR)
Is there any benefit from either ramipril or rosiglitzone among patients with impaired fasting glucose or impaired glucose tolerance?
June 23, 2009
-
Timing of Intervention in Patients With Acute Coronary Syndromes (TIMACS)
Timing is All -- Or Is It? What does TIMACS tell us about early intervention for ACS?
June 15, 2009
-
Clopidogrel Resistance: Significance and Management: Conversations with Experts
This important discussion among experts who are engaged with clopidrogrel resistance cover personalized medicine and what to do until we get there.
June 15, 2009
-
Ventricular Assist Devices: Which Device for Which Patient?
Ventricular assist devices (VAD) are currently being used for acute heart failure and shock, with the development of a number of new types and designs, both for temporary and more long-term support. This review discusses VAD uses and potential patient benefits.
June 02, 2009
-
Angiography Versus Intravascular Ultrasound-Directed Stent Placement (AVID)
Is IVUS-directed bare-metal stenting associated with improved clinical outcomes in patients undergoing elective PCI? What clinical characteristics give indication for using IVUS?
June 01, 2009
-
Comparison of the Coronary Vasomotor Response Associated With a Zotarolimus- vs. Sirolimus-Eluting Stent (Comparison of the Coronary Vasomotor Response Associated With a Zotarolimus- vs. Sirolimus-Eluting Stent)
May 29, 2009
-
Implications of CKD for Patients with CAD
Chronic kidney disease and cardiovascular disease combined have a relationship that is unique and complicated, going beyond traditional epidemiological risk factors.
April 15, 2009
-
Carotid Atherosclerosis Progression Trial Investigating Vascular ACAT Inhibition Treatment Effects (CAPTIVATE)
Is pactimibe more effective in reducing carotid intima-media thickness (CIMT) than placebo in patients with familial hypercholesterolemia?
April 14, 2009
-
CCA Focus: The DAVID II Trial
The DAVID II trial evaluated atrial pacing in patients with reduced LVEF and an ICD but no clinical indication for pacing. Learn more in this expert interview.
April 13, 2009
-
Comparison of Weight-Loss Diets With Different Compositions of Fat, Protein, and Carbohydrates
March 26, 2009
-
Dual Chamber and VVI Implantable Defibrillator II (DAVID II)
Is atrial pacing a safe alternative to ventricular backup pacing in defibrillator recipients with impaired ventricular function?
March 20, 2009
-
Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention (BRIEF-PCI)
Do patients undergoing uncomplicated PCI receive the same benefit with shorter duration eptifibatide infusions as they would with infusions of a longer duration?
March 19, 2009
-
Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Native Coronary Artery Lesions (SPIRIT III: 8-Month and 2-Year Results)
Is treatment with an everolimus-eluting stent superior to a paclitaxel-eluting stent in patients undergoing elective percutaneous coronary intervention for de novo coronary lesions?
February 12, 2009
-
Alternans Before Cardioverter Defibrillator (ABCD)
Microvolt T-wave alternans directed therapy is compared with EPS directed therapy in predicting ventricular tachyarrhythmic events in patients with ischemic cardiomyopathy.
February 11, 2009
